4.7 Article

MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis

期刊

LANCET NEUROLOGY
卷 14, 期 4, 页码 443-454

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(14)70294-7

关键词

-

资金

  1. Bayer Schering
  2. Biogen Idec
  3. Merck Serono
  4. Novartis
  5. TEVA Neurosciences
  6. Italian Ministry of Health
  7. AriSLA-Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
  8. Fondazione Italiana Sclerosi Multipla
  9. Bayer Schering Pharma
  10. Teva Pharmaceutical Industries
  11. Cure PSP
  12. Alzheimer's and Drug Discovery Foundation
  13. Jacques and Gloria Gossweiler Foundation (Switzerland)
  14. Wellcome Trust
  15. MS Society of Great Britain and Northern Ireland
  16. UCL Biomedical Research Centre
  17. Engineering and Physical Sciences Research Council
  18. Actelion
  19. Addex
  20. Advancell
  21. Allozyne
  22. BaroFold
  23. Bayer Health Care Pharmaceuticals
  24. Bayhill
  25. Biotica
  26. CLC Behring
  27. Elan
  28. Genentech
  29. GeNeuro SA
  30. Genmab
  31. Genmark
  32. Genzyme
  33. GlaxoSmithKline
  34. Johnson Johnson
  35. Lilly
  36. Mitsubishi Pharma
  37. Novo Nordisk
  38. Octapharma
  39. Peptimmune
  40. Praxicon
  41. Roche
  42. Sanofi-Aventis
  43. Santhera
  44. Siemens
  45. Teva
  46. UCB
  47. Xenoport
  48. Wyeth
  49. MRC [G0700238] Funding Source: UKRI
  50. Medical Research Council [G0700238] Funding Source: researchfish

向作者/读者索取更多资源

The spinal cord is a clinically important site that is affected by pathological changes in most patients with multiple sclerosis; however, imaging of the spinal cord with conventional MRI can be difficult. Improvements in MRI provide a major advantage for spinal cord imaging, with better signal-to-noise ratio and improved spatial resolution. Through the use of multiplanar MRI, identification of diffuse and focal changes in the whole spinal cord is now routinely possible. Corroborated by related histopathological analyses, several new techniques, such as magnetisation transfer, diffusion tension imaging, functional MRI, and proton magnetic resonance spectroscopy, can detect non-focal, spinal cord pathological changes in patients with multiple sclerosis. Additionally, functional MRI can reveal changes in the response pattern to sensory stimulation in patients with multiple sclerosis. Through use of these techniques, findings of cord atrophy, intrinsic cord damage, and adaptation are shown to occur largely independently of focal spinal cord lesion load, which emphasises their relevance in depiction of the true burden of disease. Combinations of magnetisation transfer ratio or diffusion tension imaging indices with cord atrophy markers seem to be the most robust and meaningful biomarkers to monitor disease evolution in early multiple sclerosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据